|
Market Closed -
Nasdaq
04:00:00 20/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.230 USD | +9.85% |
|
+5.19% | +62.77% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-13 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
ALLO 2.230 $
+9.85%
14.97M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ALLO | 2.230USD | +9.85% | 14.97M $ | |
CBOE
| ALLO | 2.225USD | +9.88% | 359K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 2.53 | 3.06 | 2.78 |
| Spread/Res. | -11.86% | -27.12% | -19.78% |
| Spread/Supp. | +12.63% | +34.34% | +97.35% |
| Support | 1.98 | 1.66 | 1.13 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALLO Stock
- Charts Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
